Evogene Ltd. (TLV:EVGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
478.00
+1.20 (0.25%)
Apr 1, 2025, 4:38 PM IDT

Evogene Revenue

In the year 2024, Evogene had annual revenue of $8.51M USD with 50.90% growth. Evogene had revenue of $1.61M in the quarter ending December 31, 2024, with 178.72% growth.

Revenue
$8.51M
Revenue Growth
+50.90%
P/S Ratio
0.87
Revenue / Employee
$72.74K
Employees
117
Market Cap
30.71M ILS

Revenue Chart

* This company reports financials in USD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 20248.51M2.87M50.90%
Dec 31, 20235.64M3.97M236.72%
Dec 31, 20221.68M745.00K80.11%
Dec 31, 2021930.00K-110.00K-10.58%
Dec 31, 20201.04M287.00K38.11%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Teva Pharmaceutical Industries 60.26B
Danel (Adir Yeoshua) 2.77B
Kamada 586.24M
Bait Bakfar 103.40M
Novolog (Pharm-Up 1966) 2.02B
Ilex Medical 982.96M
BrainsWay 149.39M
SofWave Medical 217.27M
Revenue Rankings